Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Hussein, Noor Ali
- Determination the levels of Bone Morphogentic Protein-2, P-Selectin, Substance P in β-Thalassemia Major in Iraqi Patients
Abstract Views :166 |
PDF Views:0
Authors
Affiliations
1 Biology Department, College of Science, University of Babylon, IQ
1 Biology Department, College of Science, University of Babylon, IQ
Source
Research Journal of Pharmacy and Technology, Vol 12, No 6 (2019), Pagination: 2677-2681Abstract
The current study aimed to assess BMP-2, P-selectin, substance-p in β-thalassemia major patients in Babylon Province (Iraq), by enrolling individual of Arab ancestry. A total of 70 beta-thalassemia major patients and 30 normal individual were enrolled Family history. All patients were blood transfusion depend with age mean (14.1±0.7years). On the other hand the selected control do not have history of family for thalassemia and doesn’t have any disease with mean age (15.6±1.2years). The result revealed significant decrease in BMP-2 in beta-thalassemia major patients, and significant increase in P-selectin, substance P in beta-thalassemia major patients.Keywords
Beta-Thalassemia Major, BMP-2, P-Selectin, Substance-P, Ferritin.
References
- Rund, D., and Rachmilewitz, E. β-Thalassemia. New England Journal of Medicine, 353(11); 2005: 1135-1146.
- Olivieri, N. F., and Brittenham, G. M Iron-chelating therapy and the treatment of thalassemia. Blood, 89(3); 1997: 739-761.
- Chen, H., Choesang, T., Li, H., Sun, S., Pham, P., Bao, W., ... and Blanc, L. Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation. Haematologica, haematol-101, 2016: 297–308.
- Sage, A., Tintut, Y., Garfinkel, A., and Demer, L. Systems biology of vascular calcification. Trends in Cardiovascular Medicine, 19(4); 2009: 118-123.
- Boström, K., Tsao, D., Shen, S., Wang, Y., and Demer, L. L. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. Journal of Biological Chemistry, 276(17); 2001: 14044-14052.
- Sato, A. Y. S., Bub, G. L., and Campos, A. H. BMP-2 and-4 produced by vascular smooth muscle cells from atherosclerotic lesions induce monocyte chemotaxis through direct BMPRII activation. Atherosclerosis, 235(1); 2014: 45-55.
- Yao, Y., Bennett, B. J., Wang, X., Rosenfeld, M. E., Giachelli, C., Lusis, A. J., and Boström, K. I. Inhibition of Bone Morphogenetic Proteins Protects Against Atherosclerosis and Vascular Calcification Novelty and Significance. Circulation Research, 107(4); 2010: 485-494.
- Cappellini, M. D., Poggiali, E., Taher, A. T., and Musallam, K. M. Hypercoagulability in β-thalassemia: a status quo. Expert Review of Hematology.2012.
- Ley, K. The role of selectins in inflammation and disease. Trends in Molecular Medicine, 9(6); 2003: 263-268.
- McEver, R. P. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thrombosis and Haemostasis, 85(03); 2001: 746-756.
- Frenette, P. S., Denis, C. V., Weiss, L., Jurk, K., Subbarao, S., Kehrel, B., and Wagner, D. D. P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet–endothelial interactions in vivo. Journal of Experimental Medicine, 191(8); 2000: 1413-1422.
- Page, N. M., Bell, N. J., Gardiner, S. M., Manyonda, I. T., Brayley, K. J., Strange, P. G., and Lowry, P. J. Characterization of the endokinins: human tachykinins with cardiovascular activity. Proceedings of the National Academy of Sciences, 100(10); 2003: 6245-6250.
- Akkerman, J. W. N. Neurotransmittors act as platelet activators. Blood, 111(2); 2008: 476-476.
- Maes, K., Nemeth, E., Roodman, G. D., Huston, A., Esteve, F., Freytes, C., and Vanderkerken, K. In anemia of multiple myeloma, hepcidinis induced by increased bone morphogenetic protein 2. Blood, 116(18); 2010: 3635-3644.
- Gardenghi, S., Ramos, P., Marongiu, M. F., Melchiori, L., Breda, L., Guy, E., and Nemeth, E. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. The Journal of Clinical Investigation, 120(12); 2010: 4466-4477.
- Babitt, J. L., Huang, F. W., Xia, Y., Sidis, Y., Andrews, N. C., and Lin, H. Y. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. The Journal of Clinical Investigation, 117(7); 2007: 1933-1939.
- Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., and Andrews, N. C. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nature Genetics, 38(5); 2006: 531.
- Truksa, J., Peng, H., Lee, P., and Beutler, E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proceedings of the National Academy of Sciences, 103(27); 2006: 10289-10293.
- Ebeid, S. A., Sadek, N. A., El-Benhawy, S. A., and Mahmoud, G. N. Plasma substance P and soluble P-selectin as biomarkers of β-thalassemia induced hypercoagulability. Alexandria Journal of Medicine, 50(2); 2014: 107-111.
- Ibrahim Z, Kamel M, Aziz A, Osman A, Salah M, and Nemenqani D. The potential role of RBCs and activated platelets in the Thalassemic hypercoagulable state. J Am Sci; 9(5); 2013: 518-524.
- Sayed, S. Z., Ali, B. A., Ali, L. H., and Mohamed, M. H. A study of CD62P (P-selectin) in β-thalassemia. The Egyptian Journal of Haematology, 37(3); 2012: 162.
- Vinchi, F., De Franceschi, L., Ghigo, A., Townes, T., Cimino, J., Silengo, L., and Tolosano, E. Hemopexin Therapy Improves Cardiovascular Function by Preventing Heme-Induced Endothelial Toxicity in Mouse Models of Hemolytic Diseases Clinical Perspective. Circulation, 127(12); 2013: 1317-1329.
- Taher, A. T., Musallam, K. M., Cappellini, M. D., and Weatherall, D. J. Optimal management of β thalassaemia intermedia. British Journal of Haematology, 152(5); 2011: 512-523.
- Ataga, K. I., Cappellini, M. D., and Rachmilewitz, E. A. β‐Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. British Journal of Haematology, 139(1); 2007: 3-13.
- Eldor, A., and Rachmilewitz, E. A. The hypercoagulable state in thalassemia. Blood, 99(1); 2002: 36-43.
- Hayashi, S. I., Watanabe, N., Nakazawa, K., Suzuki, J., Tsushima, K., Tamatani, T., and Isobe, M. Roles of P-selectin in inflammation, neointimal formation, and vascular remodeling in balloon-injured rat carotid arteries. Circulation, 102(14); 2000: 1710-1717.
- Woollard, K. J., Kling, D., Kulkarni, S., Dart, A. M., Jackson, S., and Chin-Dusting, J. Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circulation Research, 98(1); 2006: 149-156.
- Yokoyama, S., Ikeda, H., Haramaki, N., Yasukawa, H., Murohara, T., and Imaizumi, T. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates. Journal of the American College of Cardiology, 45(8); 2005: 1280-1286.
- Wagner, D. D., and Frenette, P. S. The vessel wall and its interactions. Blood, 111(11); 2008: 5271-5281.
- Abdul-Fattah ME, Ghobrial AG, Sliman GT, and Abdul-Aal AR. Rhypecoagulability and endothelial activation in β-thalassemia major: possible role of nitric oxide deficiency. (2008).
- Wu, H., Guan, C., Qin, X., Xiang, Y., Qi, M., Luo, Z., and Zhang, C. Upregulation of substance P receptor expression by calcitonin gene-related peptide, a possible cooperative action of two neuropeptides involved in airway inflammation. Pulmonary Pharmacology and Therapeutics, 20(5); 2007: 513-524.
- O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F The role of substance P in inflammatory disease. J Cell Physiol 201; 2004: 167-180.
- Kohara H, Tajima S, Yamamoto M, Tabata Y. Angiogenesis induced by controlled release of neuropeptide substance P. Biomaterials 31; 2010: 8617-8625.
- Shrestha, B., Hashiguchi, T., Ito, T., Miura, N., Takenouchi, K., Oyama, Y., and Yoshinaga, N. B cell-derived vascular endothelial growth factor A promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes. The Journal of Immunology, 184(9); 2010: 4819-4826.
- Tazzyman, S., Lewis, C. E., and Murdoch, C. Neutrophils: key mediators of tumour angiogenesis. International Journal of Experimental Pathology, 90(3); 2009: 222-231.
- Jones, S., Tucker, K. L., Sage, T., Kaiser, W. J., Barrett, N. E., Lowry, P. J.,and Gibbins, J. M. Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation. Blood, 111(2); 2008: 605-612.
- Graham, G. J., Stevens, J. M., Page, N. M., Grant, A. D., Brain, S. D., Lowry, P. J., and Gibbins, J. M.. Tachykinins regulate the function of platelets. Blood, 104(4); 2004: 1058-1065.